Skip to main content

What the FDA labels say about taking them together

Diazepam and etravirine

Etravirine's FDA label of August 15, 2023 names diazepam in its drug interactions section; the diazepam labels PlainMeds reads (4) do not name etravirine. The etravirine label: “Concomitant use of INTELENCE with diazepam may increase plasma concentrations of diazepam. A decrease in diazepam dose may be needed.”

Check it at the source: the diazepam FDA label on DailyMed (effective August 11, 2026, Waylis Therapuetics LLC); the etravirine FDA label on DailyMed (effective August 15, 2023, Janssen Products LP).

What does the diazepam label say about etravirine?

Diazepam's label (effective August 11, 2026) and its 3 other brand-application labels do not name etravirine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Valium), Waylis Therapuetics LLC, effective August 11, 2026 (SPL set 260e2041-2bb3-482f-850e-b5d47a7bdbe6), via openFDA; the full label on DailyMed

What does the etravirine label say about diazepam?

Etravirine label, drug interactions

Concomitant Drug Class/Drug Name: Benzodiazepine: diazepam; Effect on Concentration of Etravirine or Concomitant Drug: ↑ diazepam; Clinical Comment: Concomitant use of INTELENCE with diazepam may increase plasma concentrations of diazepam. A decrease in diazepam dose may be needed.

Source: FDA drug label (Intelence), Janssen Products LP, effective August 15, 2023 (SPL set 6a9cbc29-9f15-4b24-8d86-206b82887f3d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

45Diazepam generic labelers
5Etravirine generic labelers
DiazepamEtravirine
Labeled forAnxiety, Muscle spasms and spasticityHIV
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0283 per tablet 10 mg tablet$9.94 per tablet 200 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?